目的:尽管已经报道了中长期颈椎前路减压融合术(ACDF)的高融合率,ACDF后早期未融合的风险仍然很大.这项研究调查了接受单或多水平ACDF的患者的笼子未融合的早期风险因素。
方法:这是一项回顾性研究。从2020年8月到2021年12月,107名ACDF患者,包括197段,被注册,随访3个月。在197个细分市场中,155例诊断为未融合(未融合组),42例患者在ACDF后早期诊断为融合(融合组)。我们评估了患者特异性因素的意义,射线照相指示器,血清因子,和临床结果。Wilcoxon秩和检验,t检验,方差分析,采用逐步多因素logistic回归进行统计分析。
结果:单变量分析表明,吸烟,术前和术后阶段之间的C2-7Cobb角(p=0.024)和功能脊柱单位Cobb角(p=0.022)改善不足,血清钙降低(融合:2.34±0.12mmol/L;未融合:2.28±0.17mmol/L,p=0.003)1型胶原(β-CTX)的β-羧基末端端肽末端(融合:0.51[0.38,0.71];未融合:0.43[0.31,0.57],p=0.008),和骨钙蛋白的N末端片段(N-MID-BGP)(融合:18.30[12.15,22.60];未融合:14.45[11.65,18.60],p=0.023)是ACDF后早期未融合的危险因素。逐步logistic回归分析显示C2-7Cobb角改善较差(比值比[OR],1.107[1.019-1.204],p=0.017)和较低的血清钙(OR,3.700[1.138-12.032],p=0.030)是危险因素。
结论:ACDF术后成功融合的患者在3个月时比未融合的患者具有更高的术前血清钙和改善的C2-7Cobb角。这些发现表明,血清钙可用于识别ACDF后有未融合风险的患者,并且在手术期间纠正C2-7Cobb角可能会增加ACDF后早期的融合。
OBJECTIVE: Although high fusion rates have been reported for anterior cervical decompression and fusion (ACDF) in the medium and long term, the risk of nonfusion in the early period after ACDF remains substantial. This
study investigates early risk factors for cage nonfusion in patients undergoing single- or multi-level ACDF.
METHODS: This was a retrospective
study. From August 2020 to December 2021, 107 patients with ACDF, including 197 segments, were enrolled, with a follow-up of 3 months. Among the 197 segments, 155 were diagnosed with nonfusion (Nonfusion group), and 42 were diagnosed with fusion (Fusion group) in the early period after ACDF. We assessed the significance of the patient-specific factors, radiographic indicators, serum factors, and clinical outcomes. The Wilcoxon rank sum test, t-tests, analysis of variance, and stepwise multivariate logistic regression were used for statistical analysis.
RESULTS: Univariate analysis showed that smoking, insufficient improvement in the C2-7 Cobb angle (p = 0.024) and the functional spinal unit Cobb angle (p = 0.022) between preoperative and postoperative stages and lower serum calcium (fusion: 2.34 ± 0.12 mmol/L; nonfusion: 2.28 ± 0.17 mmol/L, p = 0.003) β-carboxyterminal telopeptide end of type 1 collagen (β-CTX) (fusion: 0.51 [0.38, 0.71]; nonfusion: 0.43 [0.31, 0.57], p = 0.008), and N-terminal fragment of osteocalcin (N-MID-BGP) (fusion: 18.30 [12.15, 22.60]; nonfusion: 14.45 [11.65, 18.60], p = 0.023) are risk factors for nonfusion in the early period after ACDF. Stepwise logistic regression analysis revealed that poor C2-7 Cobb angle improvement (odds ratio [OR], 1.107 [1.019-1.204], p = 0.017) and lower serum calcium (OR, 3.700 [1.138-12.032], p = 0.030) are risk factors.
CONCLUSIONS: Patients with successful fusion after ACDF had higher preoperative serum calcium and improved C2-7 Cobb angle than nonfusion patients at 3 months. These findings suggest that serum calcium could be used to identify patients at risk of nonfusion following ACDF and that correcting the C2-7 Cobb angle during surgery could potentially increase fusion in the early period after ACDF.